Professional
Added to YB: 2025-10-29
Pitch date: 2025-09-30
PBH [bullish]
Prestige Consumer Healthcare Inc.
-2.04%
current return
Author Info
No bio for this author
Company Info
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Market Cap
$2.8B
Pitch Price
$62.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.08
P/E
14.59
EV/Sales
3.38
Sector
Pharmaceuticals
Category
value
Ariel Focus Fund New Position: Prestige Consumer Healthcare Inc.
PBH (new position): OTC pharma distributor declined on mixed earnings & lowered guidance due to eye care inventory issues. Pillar5 acquisition should strengthen ophthalmic supply over time. Core portfolio delivered w/ margin expansion, FCF outlook reaffirmed for buybacks & M&A. Valuation gap vs peers.
Read full article (1 min)